InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,061.82
(
-1.20%
)
US TECH 100
17,258.44
(
0.09%
)
Dow Jones
37,735.11
(
0.00%
)
Brent Oil
89.33
(
-0.61%
)
Bitcoin
62,640.67
(
-1.23%
)
Post# of 456738
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Gernee20

Send PM Follow Ignore
Followers 28
Posts 1829
Boards Moderated 0
Alias Born 08/25/2015

Gernee20

Re: Amatuer17 post# 230752

Thursday, 01/16/2020 11:16:45 PM

Thursday, January 16, 2020 11:16:45 PM

Post# of 456738
Why do a pure phase 3 when you can do a small, inexpensive phase 2 and find out if the drug even works. Then, do a ph2/3 powered appropriately based on actual science. Cmon Amateur, you got this
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

UC Asset Expected to Report $0.03/share Net Profit for 2023 • UCASU • Apr 11, 2024 10:00 AM

Kona Gold Beverages & Apple Rush Co. Execute Joint Venture & Manufacturing Agreement • APRU • Apr 11, 2024 9:40 AM

VAYK Confirmed Its Eligibility for $1.8 Million Investment through Federal EB5 Program • VAYK • Apr 11, 2024 9:00 AM

ILUS Moves Forward With Its Two Subsidiary Uplists and Equity Dividend • ILUS • Apr 10, 2024 9:36 AM

Quartz Intersects 102m of 2.22 g/t Au and 104 g/t Ag Announces New Discovery at Prodigy on its Maestro Project, British Columbia • QZM • Apr 10, 2024 8:00 AM

Swifty Global Announces Record Annual Results Ahead of National Exchange Reverse Merger • DRCR • Apr 9, 2024 1:55 PM

Start posting your company's news
Only $200 per official company press release!